Early Stage Development - Integrated Programs

Early Stage Development - Integrated Programs

Product
Early Stage Development - Integrated Programs
Early Stage Development - Integrated Programs

Information

Accelerating molecules through to proof-of-concept - Simplify early development and accelerate to Proof-of Concept.Proof-of-concept (POC) is a key milestone in the development of a new drug candidate. We understand the transition to POC needs to be fast and cost-effective.With fully integrated capabilities from first-in-human testing to seamless drug product supply for patient trials, we simplify early development and accelerate molecules through to POC.
Distribution Areas
North America (USA, Canada)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)
Supplied From
United KingdomUnited States
Main Categories
Biopharmaceutical ProductsInnovative APIs
All Categories
Analytical Chemistry (Biopharmaceutical Products)Analytical Methods (Biopharmaceutical Products)Other APIs
Quotient SceincesQuotient Sciences brings 35+ years of trusted scientific insight, quality, and control to drug development with a mission to help our customers bring new molecules to patients faster. We provide a full range of drug product (CDMO) and clinical (CRO) services, which can be tightly integrated with Translational Pharmaceutics(R)—a disruptive platform to enable greater efficiency, better outcomes, and reduced timelines in development.

Log in

See all the content and easy-to-use features by logging in or registering!